SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Gilead raises 2026 sales outlook; Medicare cuts Biktarvy price 38% in 2028

Gilead raised its 2026 sales outlook and said Medicare will cut Biktarvy’s price by 38% starting in 2028.

GILD
SquawkNews Desk 1 updates Updated Oct 29, 2026, 09:38 PM UTC

Story updates

09:38:19 PM UTC
SquawkNews
By Deena BeasleyGilead Sciences NASDAQ:GILD hiked its full-year sales outlook on Thursday and reported third-quarter product sales rose 13%, driven by a double-digit percentage jump for its flagship HIV drug franchise.The company reported quarterly adjusted earnings of $2.55 per share on revenue of…

Related stories

BrightSpring Q3 Adjusted EBITDA Rises 42% to $227.76 Million BrightSpring reported Q3 2026 adjusted EBITDA of $227.76 million, up 42% year over year. M impact | EARNINGS | Oct 30, 2026, 10:05 AM UTC BP earnings above expectations at 0.54 USD BP (BP) released earnings per share at 0.54 USD, compared to market expectations of 0.23 USD. H impact | EARNINGS | Oct 30, 2026, 10:02 AM UTC AstraZeneca Reports 7% Nine-Month Revenue Growth, Reiterates FY26 Guidance Revenue for the nine months ended September 30 rose 7% to $46.88 billion. Reported EPS increased 10% to $5.62, while operating profit rose 10% to $11.80 billion and underlying earn M impact | EARNINGS | Oct 30, 2026, 09:58 AM UTC SCOR’s Third-Quarter Net Profit Falls Less Than Expected M impact | EARNINGS | Oct 30, 2026, 09:45 AM UTC Sun Pharma Profit Falls on Costs Tied to Organon Deal Sun Pharma said profit fell due to expenses related to its Organon transaction, while specialty drug sales remained solid. M impact | EARNINGS | Oct 30, 2026, 09:19 AM UTC Magna Beats Q3 Adjusted EPS Estimates, Raises FY Free-Cash-Flow Forecast Magna reported Q3 adjusted EPS above estimates and raised its full-year free-cash-flow forecast. M impact | EARNINGS | Oct 30, 2026, 09:13 AM UTC